Clinical Trials Update: April 13, 2007

Hepatitis Schizophrenia and Schizoaffective Disorders Heartburn

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Hepatitis

You may be eligible to participate in this study if you are at least 18 and have chronic hepatitis B. However, you will be ineligible if you have had pancreatitis, have taken nucleoside or nucleotide analogue antiviral drugs, have been treated with interferon or other immuno-stimulators in the last 24 weeks, have HIV, hepatitis C or hepatitis D, are pregnant, breastfeeding, or intend to become pregnant during the study.

The research site is in Manhasset, NY.

More information

Please see http://www.centerwatch.com/patient/studies/cat79.html.

-----

Schizophrenia and Schizoaffective Disorders

This study will evaluate an investigational agent for people with predominantly negative symptoms of schizophrenia. Those who complete the six-month study may be eligible to participate in a second study and receive an additional six months of treatment. Participants must have stable negative symptoms prior to study entry, and additional criteria apply.

The research site is in Bingham Farms, Mich.

More information

Please see http://www.centerwatch.com/patient/studies/cat135.html.

-----

Heartburn

Participants in this study of frequent heartburn will receive study related tests and examinations, as well as study medication at no cost. Compensation is available for time and travel expenses. Patients must be 18 or older with at least two episodes of nighttime heartburn per week and at least two episodes of daytime heartburn per week.

The research site is in Phoenix, Ariz.

More information

Please see http://www.centerwatch.com/patient/studies/cat175.html.

-----

Copyright 2007 Thomson CenterWatch. All rights reserved.

Consumer News